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1. Introduction 
Earlier works have suggested that CAMP would act 
as a second messenger in the action of gonadotropins 
on placental metabolism, particularly on oestrogen 
biosynthesis and glycogenolysis [l] . 
Adenylate cyclase [2,3] and phosphodiesterase [4] 
activities have been found in human placenta. The 
adenylate cyclase is responsive to prostaglandins [5] 
and catecholamines [3]. The effect of HCG is somewhat 
controversial; some found no effect [3], others found 
a significant CAMP accumulation in incubated slices 
1671. 
In the present communication we show that LH, 
HCG, PGEl and PGF,, induces a marked increase in 
the intracellular CAMP concentration of perfused human 
placenta. 
2. Materials and methods 
The following chemicals were used: 8-[3H]cyclic 
AMP (27 Ci/mole) (Radiochemical Centre Amersham, 
England), CAMP (Calbiochem), beef heart 3’5’-cyclic 
nucleotide phosphodiesterase (0.45 punits/mg protein) 
t Abbreviations: CAMP, cyclic 3’S’-adenosine monophosphate; 
HCG, human chorionic gonadotropin; LH, human luteinizing 
hormone; PC, prostaglandin. 
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(Sigma), Indomethacin (Merck, Sharp and Dohme), 
Nitrocellulose filters (0.45 pm) (Schleicher Schiill, 
Germany). The protein kinase inhibitor was either 
prepared according to Gilman [9] or supplied by Sigma. 
The following products were gifts from: Endopancrine 
(Paris, Dr Lecoq); HCG, Laboratoires s&obiologiques 
(Nancy, Dr Pauly); LH (GMM - 40 U/IR Pz, lot 717), 
Upjohn (Paris); prostaglandins. 
2.1. Perfusion of platen ta 
Full term placentas obtained after normal vaginal 
delivery were perfused within 30 min with 1 litre of a 
solution containing 9 g NaCl and 2 g glucose, pH 7.4 
at 37°C in a closed circuit. Unless otherwise stated the 
hormone was added at once in the perfusion medium 
after 20 min equilibration. At the indicated times a 
piece of approximately 300 mg of tissue was taken off 
from the same cotyledon, immediately frozen in liquid 
nitrogen and kept at -80°C until extracted. 
2.2. PurifSzation of protein kinase 
Purification of the protein kinase was performed 
according to Reimann [8], except that the hydroxy- 
lapatite and calcium phosphate steps were omitted. 
The enzyme was stored frozen at -80°C without loss 
of CAMP binding activity during more than 18 months. 
2.3. CAMP assay 
The frozen tissue was extracted and assayed accord- 
ing to Gilman [9] . 
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All determinations were done in duplicate, using 
different dilutions corresponding to l-l 5 mg of 
placenta. When the amount of tissue was higher than 
15 mg per assay an inhibitory effect on the CAMP 
binding was observed which prevented any estima- 
tion. The different substances used in the perfusion 
have no effect on the CAMP binding assay. In some 
samples the specificity of the assay was checked by 
the disappearance, of the substance which competes 
tes with [” H] CAMP, after hydrolysis by 
phosphodiesterase. 
3. Results and discussion 
Fig. IA shows a two fold increase in CAMP produc- 
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Fig. I. Time course of CAMP accumulation in human placenta 
perfused with LH, HCG, PGE, and PGFz~ After control 
perfusion (0.9% NaCl, 0.2% glucose) during 20 min, the total 
amount of hormone was added by flush injection in the 
recirculating medium at the time indicated by the arrow. 
CAMP contents expressed as pmoles/mg of wet weight tissue 
are mean values *SD of 6- 15 determinations on the same 
sample. A: - human LH (40 IU), ----- control 
perfusion; B: HCG (20 000 IU). C: PGE, (3 X low6 M); 
D: PGF2, (3 X 1O-6 M). 
tion, obtained 4-6 min after the addition of 40 i.u. 
LH. The stimulation produced by the introduction of 
20 000 i-u. HCG (fig. 1 B) is almost equal and occurs 
at an identical time. The s~uItaneous addition of 
5 mM theophylline potentiated this effect and prevent. 
ed the rapid decline in the CAMP concentration after 
the m~imum was reached. 
PGEr (3 X lOwe’ M) elicited a biphasic response 
(fig. 1C). The first peak occurred 2 min after the 
introduction of the prosta~andin and the second 8 
min later. With the same concentration of PGF*a we 
obtained a similar profile although less marked (fig. 
1D). At present we have no explanation for the 
existence of the two peaks. 
Although several authors suggested that the action 
of trophic hormones was mediated through 
prostaglandins 17,101, no direct evidence could be 
obtained up to now [ 1 l] . In one experiment we also 
could not suppress the increase in the LH-stimulated 
CAMP production, by perfusion 20 min before the 
addition of the hormone, of 50 mg indomethacin 
(0.15 X 10e3 M), a known inhibitor of prostaglandin 
biosynthesis. On the contrary the stimulation peak 
was 3-fold that observed when LH is added alone. The 
inhibitory effect of indomethacin on the placental 
cup-phosphodiesterase activity cannot account 
entirely for this stimulation. 
Quantitative differences exist in the CAMP concen- 
tration in each set of experiments, due to the 
heterogeneity of the tissue and the physiological state 
of the placenta, but the shapes of the curves were 
identical for each perfusion performed in duplicate or 
triplicate. 
The results presented here should be compared to 
previous findings dealing with the ho~one-stimulated 
production of oestrogen in the perfusion Quid [ lf , 
There is a stricking parallelism between the intensities 
of the CAMP accumulation in the tissue and the 
aromat~ation process elicited by the different 
substances. In both cases the stimulation by the PGEr 
is markedly higher than that produced by the other 
hormones. Moreover the duration of the prosta~andin 
effect on both parameters is longer than that of the 
gonadotropins, perhaps due to its inhibitory action on 
the phosphodiesterase (F. Ferre, personal ~ommuni~a- 
tion). 
Simultaneously to the CAMP determinations, in the 
same perfusion experiments, an activation of the 
147 
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phosphorylase by these hormones was observed 
(A. Auguy, L. Cedard, unpublished results). This can 
explain the increased glucose level in the perfusion fluid, 
previously measured [l] . It can be assumed that glucose 
is used, via the pentose pathway, for the production 
of NADPH necessary to the C 1 9 -hydroxylation. These 
observations can be accounted by the scheme proposed 
by Haynes et al. [ 121 and Marsh et al. [ 131. This 
again is in agreement with the similar enhancement in 
the aromatization process following the addition of a 
NADPH-regenerating system [l] . 
All these results support the hypothesis that at 
least, part of the effects of gonadotropins and 
prostaglandins on oestrogen biosynthesis are mediated 
by CAMP. 
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